Hammer Toe Syndrome

SAINT SIMONS ISLAND, Ga., Oct. 10, 2023 /PRNewswire/ -- Intelivation Technologies, an innovative medical device company with a cutting-edge orthopedic portfolio announced today that it has received clearance from the Food and Drug Administration for its Hammerdesis™ Interphalangeal Fusion System. Hammerdesis™ allows surgeons to correct hammertoe deformities and degenerative issues in patients by simply affixing a distinctively designed implant on the patient's toe joint. This one-of-a-kind operation benefits both surgeons and patients by saving surgeons significant intraoperative time and yielding cost savings for patients in the ambulatory surgery setting. Dr. David Murphy, DPM FACFAS remarked, "Hammerdesis™ provides patients with a more reliable, and a more consistent option to fix hammertoe issues. My surgeon colleagues and I are excited to use this novel system, and I am looking forward to seeing our patients benefit from Hammerdesis™." President of Intelivation, Amit Sinha, added, "There is nothing on the market today like the Hammerdesis™ procedure. This is a truly disruptive technology in a crowded area. Our product development and sales teams are looking forward to being a part of this market transformation that will make a major impact for surgeons and their patients for many years to come. We are currently preparing for our launch and post-market clinical data points to share with the orthopedic and podiatric communities." Intelivation will be exhibiting this exciting product and others at the annual ACFAS Meeting, being held February 1-4, 2024 in Tampa, Florida. About Intelivation Technologies Intelivation Technologies, dedicated to research and development, is focused on bringing paradigm-changing products to market that make patients' lives better. For further inquiries, interested parties may email [email protected]. SOURCE Intelivation Technologies

CAMP HILL, Pa.--(BUSINESS WIRE)-- Forma Medical, an emerging innovator in medical device technologies, announces today the launch of OptimalHT, the world’s first instrumented Minimally Invasive Surgery (MIS) Hammertoe Arthrodesis procedure, that has treated more than 50 hammertoe deformities. OptimalHT received FDA approval in July and is the company’s inaugural product launch. “It’s no secret that minimally invasive surgery is the future of Foot and Ankle care,” said Dr. Noman Siddiqui, DPM, LifeBridge Health, Baltimore. “The novel OptimalHT approach for digital correction is ideal for less invasive surgery in the foot to reduce edema, expedite recovery, and achieve the results my patients demand.” Less invasive than other hammertoe-specific products on the market, OptimalHT is a uniquely instrumented procedure designed to provide repeatable outcomes with minimal incisions. It is also more cost effective and scalable than other attempts at hammertoe-specific products. “Receiving our first FDA approval and launching the OptimalHT system represents a pivotal moment for Forma Medical,” said James Gault, Vice President of Forma Medical. “With this FDA approval, we now have a platform to launch life-changing systems across multiple anatomies. We are continuing to push the envelope and expand our portfolio to advance patient care.” According to the US Census Bureau, the country is seeing unprecedented growth in the active aging population. With the number of people experiencing painful hammertoe deformities at an all-time high, and expected to rise, the need to better meet patient expectations is imperative. “Retrograde k-wire fixation has been an acceptable treatment for decades, yet I've recently come to appreciate that some patients are returning to my practice years later with recurrent toe deformities. When I give them the choice, they also seem to be less tolerant of the pins sticking out of the toe and more inclined to pursue a quicker return to standard footwear,” says Jesse Doty, MD, Erlanger Health System, Chattanooga. “With OptimalHT, it's been seamless for me to incorporate the proven results of a k-wire or to take it a step further with more reliable fixation in a repeatable way that my patients find less inconvenient.” Forma Medical will debut OptimalHT at the American Orthopedic Foot & Ankle Society (AOFAS) Annual Meeting in September. For more information about Forma Medical and to learn about the company’s groundbreaking procedures, please visit or . About Forma Medical Forma Medical is a leading medical technology company dedicated to advancing orthopedic solutions. With a focus on innovation and patient-centric care, Forma Medical develops and manufactures state-of-the-art implants and instruments for orthopedic surgery. The company's mission is to advance patient care through the design, development, manufacturing, and distribution of next generation orthopedic devices.

WASHINGTON, Pa., Feb. 13, 2023 /PRNewswire/ -- Sham J. Persaud, DPM, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical field. Continue Reading Sham J. Persaud Dr. Persaud completed a Bachelor of Science degree with a Minor in Chemistry at St. Leo University, graduating cum laude in 2010. He earned a DPM degree in 2015 from Rosalyn Franklin University in Chicago, IL. Dr. Persaud completed a podiatric residency in 2018 at West Penn Foot and Ankle Institute (Allegheny Health Network). He then completed a Foot and Ankle Trauma and Reconstruction Fellowship at Mon Valley Hospital in 2019. The doctor is board qualified in foot and ankle reconstruction and surgery and provides foot and ankle surgeries to patients suffering from severe trauma. Dr. Persaud previously worked at the East Orange VA Medical Center and is now at Advanced Orthopaedics and Rehabilitation. According to the doctor, he meets with patients and examines them to determine their diagnosis and treatment plan in his day-to-day work. He performs ankle and foot surgeries, usually to fix the results of a traumatic injury. He has personal experience with trauma injuries and is passionate about helping his patients regain foot and ankle function and helping them recover as quickly as possible. Dr. Persaud has an active affiliation with the American College of Foot and Ankle Surgeons, the American Podiatric Medical Association, and the American Society of Podiatric Surgeons. Dr. Persaud also examines patients for other podiatric conditions, such as flat feet, heel pain/spurs, plantar fasciitis, athletic injuries, ankle sprains, neuroma/pinched nerves, and hammertoes. He notes that the facility has the latest treatments for foot healthcare, including in-office x-rays, platelet-rich plasma therapy, bracing, custom prescription orthotics, and both hospital and in-office surgery. Dr. Persaud was recognized by Health News Today in 2022 for his excellent work in the Medical Field and is the recipient of various prestigious awards in the field, including the 2018 ACFAS Poster Award Winner, Dr. Phillip R. Brachman Alumni Association Scholarship, and the Schill Distinguished Scholar Award. He dedicates this honorable recognition to his mentors, Mark Hofbauer, DPM, Alan Catanzariti, DPM, and Arthur Valadie, MD. He would also like to thank his fiancé and his family for all their love and support. For more information, visit persaudfootandankle.com. Contact: Katherine Green 516-825-5634 [email protected] SOURCE Continental Who's Who